| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | 0.081 | 0.2 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | 0.083 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.038 | 0.2 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |